Causal Associations and Potential Mediating Factors Between Sarcopenia-related Traits and Cardiometabolic Multimorbidity: A Mendelian Randomization Study
Weak muscles independently increase cardiometabolic disease risk through inflammation, supporting exercise as preventive medicine.
This Mendelian randomization study provides causal evidence linking low muscle mass and grip strength to cardiometabolic multimorbidity, identifying mediating mechanisms including insulin resistance and inflammation. Findings support integrating sarcopenia assessment into preventive cardiology and metabolic medicine to address a modifiable cardiometabolic risk factor.
What the study was
- Study design
- Two-sample two-step Mendelian randomization study
- Population
- Population-based GWAS samples for sarcopenia-related traits and cardiometabolic multimorbidity
- Category
- Public Health
- Maturity
- Exploratory
- Journal
- Cardiology
Why it surfaced
MR causal evidence for sarcopenia driving cardiometabolic multimorbidity; strengthens case for muscle-targeted prevention strategies in cardiovascular risk management.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.